Atypical antipsychotic drugs: Part 1

被引：0
作者：
Keltner, NL [1 ]
Coffeen, H [1 ]
Johnson, JE [1 ]
机构：
[1] Univ Alabama, Birmingham, AL 35294 USA
来源：
PERSPECTIVES IN PSYCHIATRIC CARE | 2000年 / 36卷 / 03期
关键词：
atypical antipsychotics; clozapine; risperidone;
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
This column on atypical antipsychotics is the first of two parts. Part I consists of a review of foundational information and a discussion on clozapine and risperidone. Part II will address olanuzpine, quetiapine, and ziprasidone.
引用
收藏
页码：101 / 104
页数：4
相关论文
共 50 条
  • [1] Tardive dyskinesia and atypical antipsychotic drugs
    Casey, DE
    SCHIZOPHRENIA RESEARCH, 1999, 35 : S61 - S66
  • [2] Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia
    Revicki, DA
    SCHIZOPHRENIA RESEARCH, 1999, 35 : S101 - S109
  • [3] Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders.
    Zarate C.A.
    Vemuri M.
    Cavanagh S.
    Land M.
    Current Psychiatry Reports, 2000, 2 (4) : 291 - 297
  • [4] Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs
    Julian N. Trollor
    Xiaohua Chen
    Perminder S. Sachdev
    CNS Drugs, 2009, 23 : 477 - 492
  • [5] Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs
    Trollor, Julian N.
    Chen, Xiaohua
    Sachdev, Perminder S.
    CNS DRUGS, 2009, 23 (06) : 477 - 492
  • [6] Voltammetric Analysis of Atypical Antipsychotic Drugs with Solid Electrodes
    Kul, Dilek
    CURRENT ANALYTICAL CHEMISTRY, 2019, 15 (03) : 240 - 248
  • [7] Therapeutic drug monitoring: Chemical-clinical correlations of atypical antipsychotic drugs
    Raggi, MA
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (14) : 1397 - 1409
  • [8] Metabolic Consequences of Atypical Antipsychotic Drugs
    Harold E. Lebovitz
    Psychiatric Quarterly, 2003, 74 : 277 - 290
  • [9] Update on Typical and Atypical Antipsychotic Drugs
    Meltzer, Herbert Y.
    ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 : 393 - 406
  • [10] Metabolic consequences of atypical antipsychotic drugs
    Lebovitz, HE
    PSYCHIATRIC QUARTERLY, 2003, 74 (03) : 277 - 290
12345